INZENTIZ BV creates an FDA/CE Class IIb API software platform (suited for Class I and IIa applications) which contains 80% of the software of any mobile MD application (inclusive the platform's MDD file). It thus frees the manufacturer for up to two-third of the work. INZENTIZ's price strategy facilitates a substantial cut in the development costs. The reduction in development time results in an much faster time-to-market. The platform meets all relevant standards like IEC13485, IEC62304, IEC82304, ISO2700x, ISTQB etcetera.
Inzentiz receives financial support from the European Fund for Regional Development in the context of the operational programme Oost-Nederland 2014-2020. We use this aid is to realize the Inzentiz medical platform. This supports disruptive innovation in the medical field and improves medical care.